找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Regulatory and Economic Aspects in Oncology; Evelyn Walter Book 2019 Springer Nature Switzerland AG 2019 Cancer.Targeted Therapy.Monoclona

[復(fù)制鏈接]
查看: 44967|回復(fù): 48
樓主
發(fā)表于 2025-3-21 18:49:40 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Regulatory and Economic Aspects in Oncology
編輯Evelyn Walter
視頻videohttp://file.papertrans.cn/826/825767/825767.mp4
概述Addresses key issues relating to the increasing expenditure on new targeted cancer therapies.Discusses the evaluation of benefits, harms, and costs.Examines drug pricing and drug price regulation in d
叢書名稱Recent Results in Cancer Research
圖書封面Titlebook: Regulatory and Economic Aspects in Oncology;  Evelyn Walter Book 2019 Springer Nature Switzerland AG 2019 Cancer.Targeted Therapy.Monoclona
描述.This book explores topics of importance to all who have an interest in economic methods for assessment of the efficacy and effectiveness of new cancer treatments and in regulatory measures relating to their marketing authorization and pricing. Targeted therapies and modern immunotherapy are placing a substantial strain on health care budgets. Regulation and economic methods to assess the parameters for establishing efficacy and effectiveness are therefore of prime importance. Payer authorities have to determine whether the use of these novel therapies yields clinical benefits that justify their increasing cost. In the simplest terms, cost-effectiveness analyses quantify the ratio between the extent to which an intervention raises healthcare costs and the extent to which it improves health outcomes. Rigorous cost-effectiveness analyses translate all health outcomes into quality-adjusted life years. On the other hand, in order to sustain innovation, price regulations must be coupled with efforts to ensure that drug companies are still able to recoup their investments in high-risk and high-costs research programs. Ultimately, decisions regarding health care expenditures are also a qu
出版日期Book 2019
關(guān)鍵詞Cancer; Targeted Therapy; Monoclonal antibodies; Personalized Cancer Therapy; Immunotherapy; Health Econo
版次1
doihttps://doi.org/10.1007/978-3-030-01207-6
isbn_ebook978-3-030-01207-6Series ISSN 0080-0015 Series E-ISSN 2197-6767
issn_series 0080-0015
copyrightSpringer Nature Switzerland AG 2019
The information of publication is updating

書目名稱Regulatory and Economic Aspects in Oncology影響因子(影響力)




書目名稱Regulatory and Economic Aspects in Oncology影響因子(影響力)學(xué)科排名




書目名稱Regulatory and Economic Aspects in Oncology網(wǎng)絡(luò)公開度




書目名稱Regulatory and Economic Aspects in Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Regulatory and Economic Aspects in Oncology被引頻次




書目名稱Regulatory and Economic Aspects in Oncology被引頻次學(xué)科排名




書目名稱Regulatory and Economic Aspects in Oncology年度引用




書目名稱Regulatory and Economic Aspects in Oncology年度引用學(xué)科排名




書目名稱Regulatory and Economic Aspects in Oncology讀者反饋




書目名稱Regulatory and Economic Aspects in Oncology讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:16:03 | 只看該作者
Evelyn Walter knowledge representation systems, natural language understanding systems, or multiagent systems. Modal logics are the obvious formalism for this goal, the one which has been most widely proposed and studied in the logic and philosophical literature. However, as already discussed in detail in [Giunc
板凳
發(fā)表于 2025-3-22 03:25:13 | 只看該作者
地板
發(fā)表于 2025-3-22 06:26:51 | 只看該作者
5#
發(fā)表于 2025-3-22 10:19:48 | 只看該作者
6#
發(fā)表于 2025-3-22 15:53:40 | 只看該作者
Mondher Toumi,Szymon Jaros?awski,Christos Chouhaid,Bruno Fallissard,P. Auquiereffort to propose a metric than it does to produce a convincing validation of its utility. The outcome is a plethora of what might be regarded as putative metrics and a corresponding scarcity of properly validated metrics. This paper outlines a method for the formal evaluation of a software metric a
7#
發(fā)表于 2025-3-22 19:15:21 | 只看該作者
Mandi Pratt-Chapman,Afsan Bhadeliaeffort to propose a metric than it does to produce a convincing validation of its utility. The outcome is a plethora of what might be regarded as putative metrics and a corresponding scarcity of properly validated metrics. This paper outlines a method for the formal evaluation of a software metric a
8#
發(fā)表于 2025-3-22 23:46:29 | 只看該作者
Evelyn Walter very simple, but fundamental.principles of measurement can have an extremely beneficial effect in the field of software measurement. Simply interpreting the formal definition of measurement in the software context leads to: (i) rationalizing and relating the various diverse software metrics activit
9#
發(fā)表于 2025-3-23 02:14:13 | 只看該作者
10#
發(fā)表于 2025-3-23 08:55:27 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-24 07:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
哈尔滨市| 平湖市| 资阳市| 广丰县| 德保县| 兴国县| 仙桃市| 镇远县| 扎兰屯市| 措勤县| 新安县| 韩城市| 军事| 小金县| 古交市| 申扎县| 保靖县| 平果县| 乌兰浩特市| 太白县| 郑州市| 博湖县| 重庆市| 仁寿县| 平阳县| 乌兰浩特市| 惠东县| 定安县| 抚州市| 沅陵县| 宽甸| 河东区| 宁河县| 门头沟区| 定州市| 城固县| 仁怀市| 双流县| 武隆县| 宁陵县| 唐河县|